Kinfo
Impact BioMedical Inc. logo

Impact BioMedical Inc.

IBONYSEHealthcare·US · USD
$4.11
-0.37 (-8.26%)
Prices as of October 8, 2026 · market closed

Price

Key statistics

Valuation
Market cap35.11M USD
Enterprise value41.51M USD
Trailing P/E0.38
Forward P/E0.00
PEG ratio-0.00
Price / sales1,039.89
Price / book3.38
Profitability
Gross margin66.67%
Operating margin-23400.00%
Profit margin2260.00%
Return on assets-17.79%
Return on equity23.46%
Income (TTM)
Revenue35.00K USD
Gross profit-389.00K USD
EBITDA-3.95M USD
Net income791.00K USD
Diluted EPS$11.11
Rev. growth (YoY)-57.10%
Balance sheet
Total cash10.00K USD
Total debt0.00 USD
Debt / equity9.49
Current ratio0.16
Book value / share$1.26
Cash flow (TTM)
Operating cash flow-508.00K USD
Levered free cash flow1.02M USD
Shares & price
Shares outstanding107.82M
Float910.34K
Held by institutions3.56%
Beta2.73
50-day MA$5.83
200-day MA$6.52
52-week high$10.51
52-week low$4.06
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-080.040.05+25.00%2026-04-293.694.10+11.11%2026-03-310.590.66+11.86%2025-10-130.020.03+50.00%
About Impact BioMedical Inc.

Impact BioMedical Inc. is a biotechnology company focused on discovering, validating, and commercializing science-based products and technologies for human healthcare and wellness. Its current business spans specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and direct-to-consumer wellness offerings. The company works through licensing, co-development, joint ventures, and other partnerships to advance technologies aimed at drug discovery and the prevention, inhibition, and treatment of neurological, oncologic, immune-related, and inflammatory conditions. It also develops products for broader wellness applications, including over-the-counter and consumer health categories. Based in Houston, Texas, Impact BioMedical Inc. plays a role in turning intellectual property and research-driven concepts into marketable healthcare solutions for pharmaceutical, consumer goods, and other industry partners.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Frank D. Heuszel Esq., J.D.
Employees
2
Headquarters
Houston, TX, United States

Frequently asked questions about Impact BioMedical Inc.